Intra-cellular therapies to present at the canaccord genuity 43rd annual growth conference

New york, aug. 04, 2023 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that it will present at the canaccord genuity 43rd annual growth conference on wednesday, august 9, 2023 at 1:30 p.m. et.
ITCI Ratings Summary
ITCI Quant Ranking